Apple’s smartwatch business continues to perform strongly, with a new report from DigiTimes indicating that the current Apple Watch lineup is selling nearly 10% above expectations.
Building on this success, Apple is reportedly preparing to introduce major enhancements to the Apple Watch Series 11 and Apple Watch Ultra 3, both expected to debut in 2025.
According to industry supply chain analysts, Apple is working on hardware, software, and design upgrades that will make the upcoming models stand out. Among the most anticipated features is blood pressure detection, designed primarily to track health trends and alert users when abnormal readings are detected.
The report also notes that Apple aims to introduce blood glucose monitoring to the Apple Watch in the future. However, challenges such as medical regulations, technical limitations, and ongoing patent disputes may delay the rollout of this feature.
One of the most significant improvements in the next-generation Apple Watches will be the addition of twice the number of sensors compared to current models. While the specific sensors have not been detailed, DigiTimes suggests this change will allow the devices to rely more on raw sensor data rather than algorithm-based calculations. This shift is expected to improve both accuracy and battery efficiency, addressing two of the most common concerns among smartwatch users.
Beyond health tracking, Apple is also planning a redesign of its wearable lineup. While the report did not provide details, speculation suggests slimmer bezels, new materials, and potentially a refreshed form factor to keep the Apple Watch ahead of competitors in both functionality and aesthetics.
With the Apple Watch Series 11 and Apple Watch Ultra 3 set to launch next year, Apple is positioning its smartwatch range as not just a fitness companion but also a comprehensive health-monitoring device. If these upgrades materialize, the 2025 models could mark one of the most important leaps forward in the history of the Apple Watch lineup.